The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial release generated substantial gains, the expiration of its patent opened the avenue to generic alternatives, https://socialbuzzfeed.com/story7199516/viagra-and-big-pharma-a-risky-opportunity